adenine has been researched along with sulprostone in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (66.67) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
An, S; Goetzl, EJ; Zeng, L | 1 |
Créminon, C; Levi, G; Maclouf, J; Minghetti, L; Nicolini, A; Polazzi, E | 1 |
Bai, XM; Chen, M; Guo, Y; Leng, J; Ma, J; Shu, W; Wang, YH; Wang, YP; Xia, SK; Xu, Y; Zhang, H; Zhang, L; Zhang, M | 1 |
3 other study(ies) available for adenine and sulprostone
Article | Year |
---|---|
Regulation of expression of matrix metalloproteinase-9 in early human T cells of the HSB.2 cultured line by the EP3 subtype of prostaglandin E2 receptor.
Topics: Adenine; Alprostadil; Blotting, Northern; Bucladesine; Calcium; Cell Line; Colforsin; Collagenases; Cyclic AMP; Cycloheximide; Dactinomycin; Dinoprostone; Enzyme Inhibitors; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; Kinetics; Leukemia, T-Cell; Matrix Metalloproteinase 9; Misoprostol; Prostaglandins E, Synthetic; Receptors, Prostaglandin E; RNA, Messenger; T-Lymphocytes; Thapsigargin; Transcription, Genetic; Tumor Cells, Cultured | 1996 |
Inducible nitric oxide synthase expression in activated rat microglial cultures is downregulated by exogenous prostaglandin E2 and by cyclooxygenase inhibitors.
Topics: Adenine; Adenylyl Cyclase Inhibitors; Amino Acid Sequence; Animals; Bucladesine; Cells, Cultured; Cyclic AMP; Cyclooxygenase Inhibitors; Dinoprostone; Enzyme Inhibitors; Lipopolysaccharides; Menstruation-Inducing Agents; Microglia; Molecular Sequence Data; Nitric Oxide Synthase; Rats; Receptors, Prostaglandin | 1997 |
Prostaglandin E2 promotes liver cancer cell growth by the upregulation of FUSE-binding protein 1 expression.
Topics: Abortifacient Agents, Nonsteroidal; Adenine; Adenylyl Cyclase Inhibitors; Carrier Proteins; Cell Line, Tumor; Cell Proliferation; Cell Survival; Colforsin; Cyclic AMP; Dinoprostone; DNA Helicases; DNA-Binding Proteins; Enzyme Activation; Enzyme Inhibitors; Humans; Isoquinolines; Liver Neoplasms; Nuclear Proteins; Pertussis Toxin; Phosphorylation; Protein Kinase Inhibitors; Receptors, Prostaglandin E, EP3 Subtype; Receptors, Prostaglandin E, EP4 Subtype; RNA Interference; RNA-Binding Proteins; RNA, Small Interfering; Smad2 Protein; Sulfonamides; Ubiquitination | 2013 |